China Medical System Holdings Ltd

7
1
HKSE:00867 (Hong Kong)   Ordinary Shares
HK$ 7.21 (+1.84%) Jun 5
6.73
P/B:
1.04
Market Cap:
HK$ 17.59B ($ 2.25B)
Enterprise V:
HK$ 11.95B ($ 1.53B)
Volume:
14.22M
Avg Vol (2M):
17.22M
Also Trade In:
Volume:
14.22M
Avg Vol (2M):
17.22M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for China Medical System Holdings Ltd ( ) from 2010 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. China Medical System stock (HKSE:00867) PE ratio as of Jun 05 2024 is 6.73. More Details

China Medical System Holdings Ltd (HKSE:00867) PE Ratio (TTM) Chart

To

China Medical System Holdings Ltd (HKSE:00867) PE Ratio (TTM) Historical Data

Total 1219
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
China Medical System PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-05 6.7 2024-03-27 11.7
2024-06-04 6.6 2024-03-26 11.7
2024-06-03 6.4 2024-03-25 11.5
2024-05-31 6.2 2024-03-22 11.5
2024-05-30 6.5 2024-03-21 11.8
2024-05-29 6.5 2024-03-20 11.5
2024-05-28 6.7 2024-03-19 11.3
2024-05-27 6.5 2024-03-18 11.7
2024-05-24 6.3 2024-03-15 11.5
2024-05-23 6.3 2024-03-14 11.7
2024-05-22 6.3 2024-03-13 11.6
2024-05-21 6.6 2024-03-12 11.9
2024-05-20 6.8 2024-03-11 11.6
2024-05-17 6.7 2024-03-08 11.5
2024-05-16 6.7 2024-03-07 11.3
2024-05-14 7.0 2024-03-06 11.5
2024-05-13 7.0 2024-03-05 11.5
2024-05-10 7.2 2024-03-04 12.0
2024-05-09 6.9 2024-03-01 11.9
2024-05-08 6.8 2024-02-29 12.0
2024-05-07 7.0 2024-02-28 11.8
2024-05-06 7.0 2024-02-27 11.9
2024-05-03 6.9 2024-02-26 11.9
2024-05-02 6.9 2024-02-23 11.9
2024-04-30 6.5 2024-02-22 12.0
2024-04-29 6.7 2024-02-21 11.9
2024-04-26 6.7 2024-02-20 11.4
2024-04-25 6.6 2024-02-19 11.0
2024-04-24 6.6 2024-02-16 11.2
2024-04-23 6.6 2024-02-15 10.8
2024-04-22 6.7 2024-02-14 10.7
2024-04-19 6.5 2024-02-09 10.8
2024-04-18 6.6 2024-02-08 10.9
2024-04-17 6.6 2024-02-07 10.8
2024-04-16 6.7 2024-02-06 10.9
2024-04-15 6.7 2024-02-05 10.5
2024-04-12 6.8 2024-02-02 10.5
2024-04-11 6.8 2024-02-01 10.5
2024-04-10 6.9 2024-01-31 10.5
2024-04-09 7.2 2024-01-30 10.7
2024-04-08 7.1 2024-01-29 11.0
2024-04-05 7.1 2024-01-26 11.0
2024-04-03 7.0 2024-01-25 11.3
2024-04-02 7.0 2024-01-24 11.2
2024-03-28 7.7 2024-01-23 11.1

China Medical System Holdings Ltd (HKSE:00867) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others.